MONTREAL, May 26, 2016 – SoundBite Medical Solutions Inc. (SBMS Inc.), a Montreal-based cardiovascular (CV) medical technology company, announced today the hiring of Mr. Marwan Abboud, an industry R&D leader in CV medical devices, to spearhead the final stages of development and commercialization of SoundBite shockwave technology in the exciting and challenging arena of chronic total occlusions (CTO’s) of the cardiovascular system.
Mr. Abboud brings over twenty three years of R&D leadership experience in CV product development. He championed R&D, at CryoCath Technologies, from 1995 to 2008, where he completed his mandate as VP, R&D. Marwan led the innovation process at CryoCath, a catheter cryoablation technology for the treatment of atrial fibrillation (AF). His name is on over one hundred and forty-eight issued US patents and patent applications, participated on two PMA and four 510k approvals during his term there.
“I am very excited about joining and leading the product development Team at SBMS Inc., says Marwan Abboud. “The technology and its value proposition in cardiovascular disease are unparalleled”.
“As CEO of CryoCath, I had the opportunity of working with Marwan for over 10 years and I know how valuable he will be to SoundBite as we move towards commercialization over the next eighteen months” says Steve Arless, Co-Founder and CEO of SBMS Inc.
SBMS Inc. initiated operations in May 2015. In just over twelve months, the Company has grown to a Team of 15 professional engineers and entrepreneurs, and advanced the technology from a university-based prototype system to an Alpha stage system designed and built under ISO design controls, ready for human clinical trials in Q3, 2016. SBMS Inc. technology delivers high energy shockwaves through .014” and .018” guidewires into the cardiovascular system to address difficult-to-cross calcified and fibrotic CTO’s. Approximately 30% to 40% of these occlusions are difficult, if not impossible, to cross, and often result in the need for bypass or amputation surgeries.
SoundBite Medical Solutions Inc. is developing proprietary shockwave technology to address significant unmet clinical needs in interventional cardiovascular therapy. Through an elegant combination of hardware and software, it can, in a very controllable manner, deliver high amplitude shockwave pulses through guidewires and other interventional tools, to specifically attack highly calcified and fibrotic tissue in the arterial vascular system, while leaving healthy, elastic vessel walls largely unharmed.
For further information on SoundBite Medical Solutions, please contact: Steve Arless, Co-Founder and CEO (email@example.com) or Francis Bellido, CFO (firstname.lastname@example.org), SoundBite Medical Solutions, 2300 Alfred Nobel, Technoparc St-Laurent, Montreal, Quebec H4S 2A4
SoundBite Medical Solutions Inc., Game Changer in CTO Treatment.